Open Access
CC BY-NC-ND 4.0 · Appl Clin Inform 2024; 15(03): 637-649
DOI: 10.1055/s-0044-1787184
Research Article

Interprofessional Evaluation of a Medication Clinical Decision Support System Prior to Implementation

Jacqueline Bauer
1   Pharmacy Department, Universitätsklinikum Erlangen and Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
,
Marika Busse
1   Pharmacy Department, Universitätsklinikum Erlangen and Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
,
Tanja Kopetzky
2   Medical Center for Information and Communication Technology (MIK), Universitätsklinikum Erlangen and Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
,
Christof Seggewies
2   Medical Center for Information and Communication Technology (MIK), Universitätsklinikum Erlangen and Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
,
Martin F. Fromm
3   Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
4   FAU NeW—Research Center New Bioactive Compounds, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
,
Frank Dörje
1   Pharmacy Department, Universitätsklinikum Erlangen and Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
4   FAU NeW—Research Center New Bioactive Compounds, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
› Institutsangaben

Funding None.
Preview

Abstract

Background Computerized physician order entry (CPOE) and clinical decision support systems (CDSS) are widespread due to increasing digitalization of hospitals. They can be associated with reduced medication errors and improved patient safety, but also with well-known risks (e.g., overalerting, nonadoption).

Objectives Therefore, we aimed to evaluate a commonly used CDSS containing Medication-Safety-Validators (e.g., drug–drug interactions), which can be locally activated or deactivated, to identify limitations and thereby potentially optimize the use of the CDSS in clinical routine.

Methods Within the implementation process of Meona (commercial CPOE/CDSS) at a German University hospital, we conducted an interprofessional evaluation of the CDSS and its included Medication-Safety-Validators following a defined algorithm: (1) general evaluation, (2) systematic technical and content-related validation, (3) decision of activation or deactivation, and possibly (4) choosing the activation mode (interruptive or passive). We completed the in-depth evaluation for exemplarily chosen Medication-Safety-Validators. Moreover, we performed a survey among 12 German University hospitals using Meona to compare their configurations.

Results Based on the evaluation, we deactivated 3 of 10 Medication-Safety-Validators due to technical or content-related limitations. For the seven activated Medication-Safety-Validators, we chose the interruptive option [“PUSH-(&PULL)-modus”] four times (4/7), and a new, on-demand option [“only-PULL-modus”] three times (3/7). The site-specific configuration (activation or deactivation) differed across all participating hospitals in the survey and led to varying medication safety alerts for identical patient cases.

Conclusion An interprofessional evaluation of CPOE and CDSS prior to implementation in clinical routine is crucial to detect limitations. This can contribute to a sustainable utilization and thereby possibly increase medication safety.

Note

This study was conducted in collaboration with members of the working group “Medication-Safety-Validators” of the Medicines Management Board of the Erlangen University Hospital.


Protection of Human and Animal Subjects

In this project no human and/or animal subjects were included.


Authors' Contributions

J.B., F.D., and M.F.F. designed the research.


All authors are responsible for all aspects of the presented work.


J.B. analyzed all data; M.B. and T.K. verified the data analyses.


J.B. and F.D. wrote the first version of the manuscript; M.F.F, M.B., T.K., and, C.S. revised the manuscript for important content.


All authors finally approved the manuscript.


Data Availability Statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.


Supplementary Material



Publikationsverlauf

Eingereicht: 15. Januar 2024

Angenommen: 01. April 2024

Artikel online veröffentlicht:
31. Juli 2024

© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany